Retatrutide 20mg Vial
£60.00
3 for £150
Storage Instructions
Store in a cool, dry place away from direct sunlight. Once reconstituted, refrigerate at 2–8°C.
Description
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This triagonist architecture represents a distinct pharmacological approach in metabolic signalling research, engaging three incretin-related receptor pathways in preclinical models.
Research Context
Preclinical studies have examined Retatrutide's binding profiles across GIP, GLP-1, and glucagon receptors, investigating downstream signalling cascades and their interactions in metabolic pathway research. Supplied exclusively for in vitro laboratory research purposes.
Related Products
This product is supplied for in-vitro laboratory research only. Not for human consumption, medical treatment, or cosmetic use.
Disclaimer for Elv8 Wellness Purchase
By purchasing from Elv8 Wellness, you acknowledge and agree that:
- Research Use Only: All products are exclusively sold for research purposes. They are not intended for human use, therapeutic, diagnostic, or clinical application.
- Not Medical Products: None of the products listed on our website are medical products, nor should they be marketed or used as such.
- Compliance and Responsibility: The buyer is responsible for ensuring compliance with all relevant laws and regulations. Elv8 Wellness holds no liability for misuse of products or any adverse outcomes.
Your purchase signifies your understanding and agreement to these terms.